CORRECTION: Athersys to Present at 25th Annual Piper Jaffray Healthcare
CLEVELAND, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX)
announced today that the Company will present at the 25^th Annual Piper
Jaffray Healthcare Conference taking place at The New York Palace on December
3^rd and 4^th, 2013 in New York City.
In a release issued earlier this afternoon, we mistakenly listed the time of
William (B.J.) Lehmann's presentation as December 4, 2013 at 4:00 pm. William
(B.J.) Lehmann, President and Chief Operating Officer, will in fact present on
Wednesday, December 4, 2013 at 8:30 a.m. Eastern Standard Time.
During the presentation, material information concerning the Company, its
operations, strategies and prospects may be discussed. To listen to the live
audio webcast of the presentation during the event, please visit:
www.athersys.com. A replay of the webcast will be available for 30 days after
the initial presentation.
Athersys is a clinical stage biotechnology company engaged in the discovery
and development of therapeutic product candidates designed to extend and
enhance the quality of human life. The Company is developing its MultiStem^®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell
product platform for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has several
clinical stage programs involving MultiStem, including for treating
inflammatory bowel disease, ischemic stroke, damage caused by myocardial
infarction, and for the prevention of graft-versus-host disease. Athersys has
also developed a diverse portfolio that includes other technologies and
product development opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology companies, as
well as world-renowned research institutions in the United States and Europe
to further develop its platform and products. More information is available at
The Athersys, Inc. logo is available at:
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
Lisa M. Wilson
Tel: (917) 543-9932
Press spacebar to pause and continue. Press esc to stop.